US20100222864A1 - Neurovascular stent and method - Google Patents
Neurovascular stent and method Download PDFInfo
- Publication number
- US20100222864A1 US20100222864A1 US12/752,847 US75284710A US2010222864A1 US 20100222864 A1 US20100222864 A1 US 20100222864A1 US 75284710 A US75284710 A US 75284710A US 2010222864 A1 US2010222864 A1 US 2010222864A1
- Authority
- US
- United States
- Prior art keywords
- stent
- strut
- catheter
- adjacent
- contracted state
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/823—Stents, different from stent-grafts, adapted to cover an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
Definitions
- the present invention relates to a vascular endoprosthesis, such as a stent, for placement in an area of a body lumen that has been weakened by damage or disease such as by aneurysm, and in particular, to a stent adapted for placement at a neurovascular site, and to a method of using the stent in treating a neurovascular aneurysm.
- a vascular endoprosthesis such as a stent
- Rupture of non-occlusive cerebrovascular lesions is a major cause of stroke.
- Rupture of an aneurysm causes subarachnoid hemorrhage in which blood from a ruptured vessel spreads over the surface of the brain.
- About 2.5% of the United States population (4 million Americans) have an unruptured aneurysm.
- About 100,000 of these people suffer a subarachnoid hemorrhage each year.
- the disease is devastating, often affecting healthy people in their 40's and 50's, with about half of the rupture victims succumbing within a month, and with half of the survivors becoming seriously disabled as a result of the initial hemorrhage or of a delayed complication.
- Neurovascular arteries are generally quite small, having diameters ranging from 2.0 to 4.0 mm in the Circle of Willis, 2.5 to 5.5 mm in the cavernous segment of the internal carotid artery, 1.5 to 3.0 mm in vessels of the distal anterior circulation; and 2.0 to 4.0 mm in the posterior circulation.
- the incidence of aneurysm varies with the location, with 55% occurring in the Circle of Willis, 30% in the internal carotid, 10% in the distal anterior circulation, and 5% in the posterior circulation. Screening for these lesions and preventing rupture will lead to better clinical outcomes and lower costs.
- Non-invasive treatments for ruptured and unruptured lesions are preferred over surgical interventions due to lower costs, lower mortality and morbidity, and patient preference.
- a stent at the site of weakened or damaged vessels.
- Such a treatment involves several daunting challenges.
- the stent must provide adequate structural support at the target site to maintain the vessel in a slightly expanded-diameter state.
- the stent design should minimize the risk of metal fatigue as the stent is placed between its expanded and compressed forms.
- the stent must provide a low profile and a surface that minimizes the formation of blood thrombi.
- the stent should provide an open-network skeleton that allows for delivery of additional agents, e g, vaso-occlusive coils, through the stent into the underlying aneurysm cavity.
- the invention includes, in one aspect, a stent designed for catheter delivery to a target neurovascular site via a tortuous path in a contracted state, and deployment at the target site in an expanded state.
- the stent includes a plurality of expandable tubular members, where each member is composed of a continuous wire element forming a plurality of wave segments, and each segment contains a pair of opposite looped peaks and has a wave shape such that the distance between adjacent sides of a wave in the stent's expanded state, on proceeding from a peak toward opposite peaks, increases monotonically with an inflection point therebetween.
- Adjacent tubular members are connected by axial connectors, preferably joining adjacent peaks of adjacent members, and preferably spaced from one another by intervening, unconnected confronting peaks. Radial expansion of the stent from a contracted to expanded state is accommodated by movement of adjacent wave-segment peaks away from one another, without significant change in the axial dimension of the stent.
- the wire elements are formed of a NiTi shape memory alloy, and radial expansion is achieved by releasing the stent from such catheter.
- the stent of this embodiment may have a stress-induced martensite phase at body temperature, and/or an austenite phase transition temperature below body temperature.
- the stent has a diameter; in its contracted state of between 0.5-2 mm, more preferably 0.71 mm to 1.65 mm, and an expansion ratio of between 2 and 9, typically 3 and 6.
- the invention includes a system for treating an aneurysm or other vascular abnormality in a neurovascular target vessel having an inner diameter less than about 8 mm and accessible via a tortuous vascular path.
- the system includes a guide wire that can be deployed at the target site, a catheter having a lumen inner diameter of 0.5 to 2 mm, and the above stent carried in its contracted state within the catheter's distal end region.
- the catheter and stent carried therein are adopted to be moved axially along the guide wire, for placing the catheter at the target site.
- a pusher wire movable through the catheter, for forcing the stent out of the catheter into the vascular site, where stent radial expansion is effective to lodge the stent at the target site.
- the pusher wire may be equipped with a distal-end stabilizer that is engageable with the stent when forcing the same from the catheter. Preferred stent features are given above.
- the invention includes a method of treating an aneurysm or other vascular abnormality in a neurovascular target vessel having an inner diameter less than about 8 mm and accessible via a tortuous vascular path.
- the method includes navigating a guide wire to the target site, and moving over the guide wire, a catheter having a lumen inner diameter of 0.5 to 2 mm, and the above stent carried in its contracted state within the catheters distal end region, until the catheter distal end is located at the target site.
- the guide wire is then replaced with a pusher wire, which is used to advance the stent out of the catheter into the vascular site, where stent radial expansion is effective to lodge the stent at the target site.
- FIG. 1 is a side view of portions of a pair of connected tubular members forming the stent of the invention, and shown in a contracted state;
- FIG. 2 shows the same tubular members in an expanded state
- FIG. 3 shows a portion of a stent constructed according to the invention, in a contracted state
- FIG. 4 shows the same portion of the stent, but in an expanded state
- FIGS. 5A and 5B illustrate the change in distance between adjacent sides of a wave segment in a tubular member, on proceeding from a lower wave peak to the opposite (upper) side of member ( 5 A), and a plot this distance as a function of the peak-to-peak distance, showing the inflection point in the distance plot;
- FIGS. 6A and 6B show various components of the system of the invention, in a stent-delivery method, and at two stages of stent delivery;
- FIGS. 7A and 7B are expanded views of distal end portions of the system, of the invention, shown in relation to a vascular target site, just prior to release at the target site ( 7 A) and after deployment at the site and stent expansion in the target vessel.
- FIGS. 1 and 2 show a portion of a stent 10 constructed in accordance with the invention, in the stent's contracted and expanded states, respectively.
- the stent includes a plurality of expandable tubular members, such as tubular members 12 , 14 .
- the stent may include many such members, e.g., 2-20, collectively forming an elongate cylindrical tube.
- Each member of the stent is formed of a continuous wire element, such as wire element 16 in member 12 , forming a plurality of wave segments, such as wave segments 18 , 20 in member 14 , whose shape and expansion characteristics will be described further below with respect to FIGS. 3-5 .
- the wave segments have opposite looped peaks, such as looped peaks 22 , 24 in wave segment 18 .
- Adjacent tubular members are connected one to another by axial connectors, such as axial connector 26 joining members 14 , 16 , and axial connector 28 joining tubular member 12 to a third member (not shown). As seen, the axial connectors connect confronting peaks in adjacent members, although connections to other parts of the wave segments is contemplated.
- the connectors are spaced from one another by at least one, and preferably three or four unconnected confronting peaks. That is, a majority of the confronting peaks are unconnected, providing greater stent flexibility in bending away from the stent long axis.
- the connectors shown here are simple linear connectors, the connectors may assume more complicated configurations, such as curved or zig-zag shapes which may themselves stretch to accommodate off-axis bending of the stent, providing greater flexibility.
- the stent has a contracted-state diameter ( FIG. 1 ) of between 0.5-2 mm, more preferably 0.71 to 1.65 mm, and a length of between about 0.5-4 cm, composed of 2-20 tubular members, each about 0.25 to 1.0 mm in length.
- the axial connectors have a length typically of 3-20% that of the tubular members.
- Each tubular member is composed of between 5-25 wave segments, defined as repeating segments of the associated wire elements, as described below with respect to FIGS. 3-5 .
- the stent diameter is at least twice and up to 8-9 times that of the stent in its contracted state.
- a stent with a contracted diameter of between 0.7 to 1.5 mm may expand radially to a selected expanded state of between 2-8 mm or more.
- FIGS. 3 and 4 show portions of the tubular members as they would appear if laid out in a plane.
- the figures show portions of tubular members 12 , 14 , each formed of a continuous wire element, such as wire element 18 forming member 14 .
- Each wire element is formed of a series of repeating-unit wave segments, such as wave segments 18 , 20 , where the “end” of one segment is the “beginning” of the next segment.
- wave segment 18 is defined as the portion of the wire element between points 30 , 32 , and segment 20 , as the portion of the element between points 32 , 34 .
- the wave segments are compressed closely together, as seen in FIG. 3 , where adjacent looped peaks are in contact with one another or nearly in contact and the looped peaks are squeezed together.
- the wave segments forming the wire element accommodate movement of the opposite arms of a wave segment, such as opposite arms 36 , 38 in segment 18 , away from one another, with relatively larger movement occurring in the center portion of the wave segment, i.e., the portion between opposite looped peaks.
- FIG. 5A shows three adjacent wave segments, including segment 18 in its expanded (or expanding) form.
- Distances between opposite sides 36 , 38 of wave segment such as distances 40 , 42 , 44 , are shown for a number of points between looped peak 46 in segment 18 and opposite looped peaks 48 in segment 18 and 50 in adjacent segment 20 .
- the x-axis represents the distance from a peak in a wave segment to the opposite peak of the wave segment, with the ordinates 40 , 42 , 44 in FIG. 5A shown.
- the distance along the y-axis represents the distance between opposite sides of the wave segment.
- the plot shows a relatively small slope ( ⁇ x/ ⁇ y) in the wave regions adjacent the peaks and the greatest slope in the center region of the segment between the looped peaks.
- the point of greatest slope corresponding roughly to midpoint 42 between the peaks, is an inflection point in the plot, as the slope of the plot increases between points 40 and 42 , then begins to decrease between points 42 and 44 .
- the distance between opposite sides of a wave segment in the contracted state is at a minimum at a point intermediate the looped peaks, where opposite sides of a wave appear to be touching in the two figures.
- the element can undergo a severalfold radial expansion by virtue of the ability to be close packed in a contracted state (unlike a sin wave), and still provide significant expansion between wave segment arms.
- This is in contrast to a sin-wave wire element in which compression at the peaks, and thus the number of wave segments that can be accommodate in the contracted state, is limited.
- the stent may be formed by conventional stent construction methods involving either initial formation of the individual tubular members, and subsequent attachment of one member to another by axial connectors, or by laser cutting a thin-walled tube to have the skeletal features making up the stent, as detailed below.
- the wire element may be formed by shaping a wire segment and joining the wire ends to form the desired tubular member.
- the wire element is formed by cutting and removing portions of a cylindrical tube.
- the stent preferably exhibits a relatively high degree of biocompatibility since it is implanted in the body.
- suitable stent materials include compressible, biocompatible polymers, ELGILOY (available from Carpenter Technology Corporation of Reading, Pa.) and PHYNOX (available from Metal Imphy of Imphy, France). Both of these metals are cobalt-based alloys which also include chromium, iron, nickel and molybdenum.
- Other materials for a self expanding stent include 316 stainless steel and MP35N alloy which are available from Carpenter Technology Corporation and Latrobe Steel Company of Latrobe, Pa., and superelastic Nitinol nickel-titanium alloy which is available from Shape Memory Applications of Santa Clara, Calif. Nitinol alloy contains about 45% titanium.
- the stent is formed of a shape-memory alloy having a final austenite transition temperature of between about 25° C. and 37° C. This feature allows the stent to be carried in the catheter in a martensitic state, and assume its preformed, austenite shape when expelled from the catheter and exposed to the higher body temperature at the target site.
- the shape-memory alloy has a transition temperature M d greater than 37° C., below which the alloy retains sufficient stress-induced martensitic property to allow placement of the stent at or above its A f .
- this allows the stent to be carried in the catheter in a stress-induced martensitic (SIM) state, and recover its preformed, austenitic shape when released from the constraints of the catheter, at a temperature that may be substantially above the final austenite temperature without significant plastic, or otherwise permanent deformation.
- the final austenite temperature may be quite low, e.g., 4° C., or it may be room temperature or higher.
- Nitinol cylindrical tubes having desired transition temperatures can be prepared according to known methods.
- a nitinol hypotube e.g., 8 mil wall thickness
- the stent pattern is cut by a laser (e.g., as described by Madou in Fundamentals of Microfabrication, CRC Press, 1997). Both inner and outer surfaces are polished to a mirror finish using electro-polish techniques (e.g., as described by Madou, 1997).
- a gold coat may be applied by ion beam assist or by sputtering.
- a radio-opaque marker may be affixed to the stent to improve radio-opacity.
- the stent is formed at the expanded condition ( FIG. 2 ), corresponding to the final deployed size (e.g. about 3-8 mm outer diameter), and heated to a temperature above the transition temperature.
- the stent is then subjected to thermoelastic martensitic transformation (e.g., as described in U.S. Pat. No. 5,190,546 incorporated by reference in its entirety herein) by cooling below the transition temperature range of the alloy and deformation to the contracted condition suitable for use within an intraluminal catheter.
- the transition temperature can be modified by varying the ratios of each metal in the alloy and in one embodiment, is preferably is within the range between about 25° C. to 45° C. at which the stent expands. A more preferred transition temperature range is between about 25° C. to 37° C.
- the alloy can comprise 55% nickel, and 45% titanium which gives a transition temperature of about 32° C. to 33° C., which is below body temperature but above room temperature.
- Nitinol cylindrical tubes having a martensite temperature M D below which the alloy can assume a stress-induced martensitic condition while being stressed to the extent necessary to place or otherwise use the device, of greater than about 37° C., preferably greater than about 40° C., are also prepared according to known methods, e.g., U.S. Pat. No. 4,505,767.
- an ideal alloy would act, at about 37° C., as a constant force spring over a strain range up to about 5% or more. This is a measurement of the degree to which an alloy, at a given temperature, can be strained in a purely austenitic state by the formation of stress-induced martensite without significant plastic deformation.
- the strain caused by the application of a given stress at a given temperature is substantially recoverable.
- the maximum stress realized occurs sometime during the process of placing a nitinol device at a given temperature. Accordingly, a suitable alloy will provide a device that is capable of substantially recovering its austenitic shape without significant plastic deformation, upon placement in the body.
- the target site in the method is typically a neurovascular site, such as site 54 , in the brain, which is accessible only via a tortuous vascular path 56 , by which is meant a vascular path containing a plurality of bends or turns which may be greater than 90 turns, and involving vessels which are less than about 8 mm, and as small as 2-3 mm, in diameter.
- a neurovascular site such as site 54
- tortuous vascular path 56 by which is meant a vascular path containing a plurality of bends or turns which may be greater than 90 turns, and involving vessels which are less than about 8 mm, and as small as 2-3 mm, in diameter.
- a guide catheter 60 is placed at the target site according to known methods. Then the target site is accessed by a flexible guidewire (such as described in U.S. Pat. No. 4,619,274) and a flexible catheter 64 . Once the target site is reached, the catheter tube is pulled out, leaving the flexible guidewire in place. The stent-delivery catheter 62 , as seen in FIG. 68 , is advanced over the guidewire until the target site is reached.
- a flexible guidewire such as described in U.S. Pat. No. 4,619,274
- stent-delivery catheter 62 The distal end of stent-delivery catheter 62 is shown in FIG. 7A , and includes a catheter 68 having an inner lumen having a diameter preferably between about 0.5 to 2 mm, e.g. 0.71 to 1.65 mm.
- a stent 70 constructed in accordance with the invention is carried in its contracted state at the distal end of the catheter.
- the guidewire is removed and replaced with a pusher wire 63 (as shown in FIG. 6B ) having a distal-end stabilizer 65 , which has a distal head surface dimensioned to engage the proximal end of the stent.
- a pusher wire 63 as shown in FIG. 6B
- a distal-end stabilizer 65 which has a distal head surface dimensioned to engage the proximal end of the stent.
- the pusher wire is advanced and pushed against the stent until the stent is pushed out of the catheter, as shown in FIG. 7B .
- the stent is free to self-expand to a diameter slightly greater than the diameter of the vascular site, thus locking the stent in place at the target site.
- the method of the invention includes navigating a guide wire to the target site, moving over the guide wire, a catheter having a lumen inner diameter of 0.5 to 2 min and a distal end region in the lumen, and the stent of the invention, carried in its contracted state within the catheter's distal end region, until the catheter distal end is located at the target site.
- the guidewire is then replaced with a pusher wire, which is advanced within the catheter to force the stent out of the catheter into the vascular site, where stent radial expansion to its expanded state is effective to lodge the stent at the target site.
- the system of the invention used in carrying out the method includes a guidewire that can be deployed at the target site, a catheter having a lumen inner diameter of 0.5 to 2 min and a distal end region in the lumen, and adapted to be placed at the target site via such path, and the stent of the invention carried in its contracted state within the catheter's distal end region, where the catheter and stent carried therein are adapted to be moved axially along the guide wire, for placing the catheter at the target site.
- a pusher wire is movable through the catheter for forcing the stent out of the catheter into the vascular site, where stent radial expansion to its expanded state is effective to lodge the stent at the target site.
- the stent and system employing the stent of the present invention can be used in the treatment of a variety of vascular lesions such as an aneurysm, fistula, occlusion, or narrowing and is particularly useful in treating targets located in tortuous and narrow vessels, for example in the neurovascular system, or in certain sites within the coronary vascular system, or in sites within the peripheral vascular system such as superficial femoral, popliteal, or renal arteries.
- vascular lesions such as an aneurysm, fistula, occlusion, or narrowing
- targets located in tortuous and narrow vessels for example in the neurovascular system, or in certain sites within the coronary vascular system, or in sites within the peripheral vascular system such as superficial femoral, popliteal, or renal arteries.
- the axial construction of the stent composed of short tubular members joined by axial connections, and the ability of the joined members to flex radially, by distributed bending within the looped regions of the wire elements, allows the stent to be moved over high-angle, small-radius bends, with relatively little localized stress and metal fatigue.
- the ability of the stent to be close-packed, in its contracted state, and have a smooth wave-like character in its expanded (and expanding) state allows the stent to expand severalfold when deployed, with a minimum risk of metal fatigue due to concentrated stresses, or damage to the vessel wall, due to sharp points on the stent.
- the stent In its expanded state, the stent provides good radial strength, for holding the stent in place.
- the stent has a low profile, which may be in the 2-4 mil range for stent thickness.
- the stent should provide an open-network skeleton that allows for delivery of additional agents, e.g., vaso-occlusive coils, through the stent into the underlying aneurysm cavity.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
Abstract
Description
- This application is a Continuation Application of and claims priority to U.S. application Ser. No. 11/393,200, now issued U.S. Pat. No. 7,695,507, which is a Continuation Application of and claims priority to U.S. application Ser. No. 09/715,878, now issued U.S. Pat. No. 7,037,330, which claims the benefit of U.S. Provisional Patent Application Ser. No. 60/241,101, filed on Oct. 16, 2000, all of which are expressly incorporated in their entireties herein by reference.
- The present invention relates to a vascular endoprosthesis, such as a stent, for placement in an area of a body lumen that has been weakened by damage or disease such as by aneurysm, and in particular, to a stent adapted for placement at a neurovascular site, and to a method of using the stent in treating a neurovascular aneurysm.
- Rupture of non-occlusive cerebrovascular lesions, such as intracranial saccular aneurysms or arterio-venous fistulae, is a major cause of stroke. Rupture of an aneurysm causes subarachnoid hemorrhage in which blood from a ruptured vessel spreads over the surface of the brain. About 2.5% of the United States population (4 million Americans) have an unruptured aneurysm. About 100,000 of these people suffer a subarachnoid hemorrhage each year. The disease is devastating, often affecting healthy people in their 40's and 50's, with about half of the rupture victims succumbing within a month, and with half of the survivors becoming seriously disabled as a result of the initial hemorrhage or of a delayed complication.
- Neurovascular arteries are generally quite small, having diameters ranging from 2.0 to 4.0 mm in the Circle of Willis, 2.5 to 5.5 mm in the cavernous segment of the internal carotid artery, 1.5 to 3.0 mm in vessels of the distal anterior circulation; and 2.0 to 4.0 mm in the posterior circulation. The incidence of aneurysm varies with the location, with 55% occurring in the Circle of Willis, 30% in the internal carotid, 10% in the distal anterior circulation, and 5% in the posterior circulation. Screening for these lesions and preventing rupture will lead to better clinical outcomes and lower costs. Non-invasive treatments for ruptured and unruptured lesions are preferred over surgical interventions due to lower costs, lower mortality and morbidity, and patient preference.
- One possible treatment for neurovascular aneurysms and other small vessel abnormalities involves placement of a stent at the site of weakened or damaged vessels. Such a treatment, however, involves several formidable challenges. First, assuming the stent is placed at the target site via a small-diameter catheter; the stent must be flexible enough to allow movement of the catheter along a typically tortuous vascular path, which may involve a number of sharp turns or bends in and through small-diameter vessels, i.e., vessels having diameters in the 2-8 mm range. Second, when the stent is released, it must be capable of expanding from the inner lumen diameter of the catheter to a diameter somewhat greater than that of the vessel at the target site, requiring an expansion ratio of at least twofold. Third, the stent must provide adequate structural support at the target site to maintain the vessel in a slightly expanded-diameter state. In particular the stent design should minimize the risk of metal fatigue as the stent is placed between its expanded and compressed forms. Fourth, the stent must provide a low profile and a surface that minimizes the formation of blood thrombi. Finally, the stent should provide an open-network skeleton that allows for delivery of additional agents, e g, vaso-occlusive coils, through the stent into the underlying aneurysm cavity.
- Although a variety of intravascular stents have been proposed heretofore, for example, in U.S. Pat. Nos. 4,512,338, 4,503,569, 4,553,545, 4,795,485, 4,820,298, 5,067,957, 5,551,954, 5,562,641, and 5,824,053, none of these structures adequately meets the several requirements outlined above. In particular, the problem of providing a stent skeletal structure that has a contracted state diameter of 0.5-2 mm, is highly flexible in a contracted state, has a high expansion ratio on delivery from a catheter, and resists metal fatigue on expanding and contracting, has not been adequately solved heretofore.
- It would therefore be valuable to provide an intravascular stent, particular one for use in treating neurovascular aneurysms and other vascular abnormalities, that provides the advantages and features mentioned above.
- The invention includes, in one aspect, a stent designed for catheter delivery to a target neurovascular site via a tortuous path in a contracted state, and deployment at the target site in an expanded state. The stent includes a plurality of expandable tubular members, where each member is composed of a continuous wire element forming a plurality of wave segments, and each segment contains a pair of opposite looped peaks and has a wave shape such that the distance between adjacent sides of a wave in the stent's expanded state, on proceeding from a peak toward opposite peaks, increases monotonically with an inflection point therebetween. Adjacent tubular members are connected by axial connectors, preferably joining adjacent peaks of adjacent members, and preferably spaced from one another by intervening, unconnected confronting peaks. Radial expansion of the stent from a contracted to expanded state is accommodated by movement of adjacent wave-segment peaks away from one another, without significant change in the axial dimension of the stent.
- In a preferred embodiment, the wire elements are formed of a NiTi shape memory alloy, and radial expansion is achieved by releasing the stent from such catheter. The stent of this embodiment may have a stress-induced martensite phase at body temperature, and/or an austenite phase transition temperature below body temperature.
- Also in a preferred embodiment, the stent has a diameter; in its contracted state of between 0.5-2 mm, more preferably 0.71 mm to 1.65 mm, and an expansion ratio of between 2 and 9, typically 3 and 6.
- In another aspect, the invention includes a system for treating an aneurysm or other vascular abnormality in a neurovascular target vessel having an inner diameter less than about 8 mm and accessible via a tortuous vascular path. The system includes a guide wire that can be deployed at the target site, a catheter having a lumen inner diameter of 0.5 to 2 mm, and the above stent carried in its contracted state within the catheter's distal end region. The catheter and stent carried therein are adopted to be moved axially along the guide wire, for placing the catheter at the target site. Also included is a pusher wire movable through the catheter, for forcing the stent out of the catheter into the vascular site, where stent radial expansion is effective to lodge the stent at the target site. The pusher wire may be equipped with a distal-end stabilizer that is engageable with the stent when forcing the same from the catheter. Preferred stent features are given above.
- In still another aspect, the invention includes a method of treating an aneurysm or other vascular abnormality in a neurovascular target vessel having an inner diameter less than about 8 mm and accessible via a tortuous vascular path. The method includes navigating a guide wire to the target site, and moving over the guide wire, a catheter having a lumen inner diameter of 0.5 to 2 mm, and the above stent carried in its contracted state within the catheters distal end region, until the catheter distal end is located at the target site. The guide wire is then replaced with a pusher wire, which is used to advance the stent out of the catheter into the vascular site, where stent radial expansion is effective to lodge the stent at the target site.
- These and other objects and features of the invention will become more fully apparent when the following detailed description of the invention is read in conjunction with the accompanying drawings.
-
FIG. 1 is a side view of portions of a pair of connected tubular members forming the stent of the invention, and shown in a contracted state; -
FIG. 2 shows the same tubular members in an expanded state; -
FIG. 3 shows a portion of a stent constructed according to the invention, in a contracted state; -
FIG. 4 shows the same portion of the stent, but in an expanded state; -
FIGS. 5A and 5B illustrate the change in distance between adjacent sides of a wave segment in a tubular member, on proceeding from a lower wave peak to the opposite (upper) side of member (5A), and a plot this distance as a function of the peak-to-peak distance, showing the inflection point in the distance plot; -
FIGS. 6A and 6B show various components of the system of the invention, in a stent-delivery method, and at two stages of stent delivery; -
FIGS. 7A and 7B are expanded views of distal end portions of the system, of the invention, shown in relation to a vascular target site, just prior to release at the target site (7A) and after deployment at the site and stent expansion in the target vessel. -
FIGS. 1 and 2 show a portion of astent 10 constructed in accordance with the invention, in the stent's contracted and expanded states, respectively. The stent includes a plurality of expandable tubular members, such astubular members - Each member of the stent is formed of a continuous wire element, such as
wire element 16 inmember 12, forming a plurality of wave segments, such aswave segments member 14, whose shape and expansion characteristics will be described further below with respect toFIGS. 3-5 . The wave segments have opposite looped peaks, such as loopedpeaks wave segment 18. Adjacent tubular members are connected one to another by axial connectors, such asaxial connector 26 joiningmembers axial connector 28 joiningtubular member 12 to a third member (not shown). As seen, the axial connectors connect confronting peaks in adjacent members, although connections to other parts of the wave segments is contemplated. In a typical stent, the connectors are spaced from one another by at least one, and preferably three or four unconnected confronting peaks. That is, a majority of the confronting peaks are unconnected, providing greater stent flexibility in bending away from the stent long axis. Although the connectors shown here are simple linear connectors, the connectors may assume more complicated configurations, such as curved or zig-zag shapes which may themselves stretch to accommodate off-axis bending of the stent, providing greater flexibility. - Preferably, the stent has a contracted-state diameter (
FIG. 1 ) of between 0.5-2 mm, more preferably 0.71 to 1.65 mm, and a length of between about 0.5-4 cm, composed of 2-20 tubular members, each about 0.25 to 1.0 mm in length. The axial connectors have a length typically of 3-20% that of the tubular members. - Each tubular member is composed of between 5-25 wave segments, defined as repeating segments of the associated wire elements, as described below with respect to
FIGS. 3-5 . In its expanded state, shown inFIG. 2 , the stent diameter is at least twice and up to 8-9 times that of the stent in its contracted state. Thus, a stent with a contracted diameter of between 0.7 to 1.5 mm may expand radially to a selected expanded state of between 2-8 mm or more. - The relationship between the shape of the wave segments in the tubular methods and the mode of radial expansion of the stent is illustrated particularly in
FIGS. 3 and 4 , which show portions of the tubular members as they would appear if laid out in a plane. In particular, the figures show portions oftubular members wire element 18 formingmember 14. Each wire element, in turn, is formed of a series of repeating-unit wave segments, such aswave segments - The “end/beginning” point of the wave segments, which occurs at the same phase point in each wave, is arbitrary, and for purposes of illustration is indicated at a point, such as indicated at 30, 32, 34, which is near the top of the loop in the upper looped peak of each wave segment. Thus,
wave segment 18 is defined as the portion of the wire element betweenpoints segment 20, as the portion of the element betweenpoints - In the stent's contracted state, the wave segments are compressed closely together, as seen in
FIG. 3 , where adjacent looped peaks are in contact with one another or nearly in contact and the looped peaks are squeezed together. According to an important feature of the invention, the wave segments forming the wire element accommodate movement of the opposite arms of a wave segment, such asopposite arms segment 18, away from one another, with relatively larger movement occurring in the center portion of the wave segment, i.e., the portion between opposite looped peaks. - This feature is illustrated particularly in
FIG. 5A , which shows three adjacent wave segments, includingsegment 18 in its expanded (or expanding) form. Distances betweenopposite sides distances segment 18 and opposite loopedpeaks 48 insegment adjacent segment 20. In the plot shown inFIG. 5B , the x-axis represents the distance from a peak in a wave segment to the opposite peak of the wave segment, with theordinates FIG. 5A shown. The distance along the y-axis represents the distance between opposite sides of the wave segment. As seen, the plot shows a relatively small slope (Δx/Δy) in the wave regions adjacent the peaks and the greatest slope in the center region of the segment between the looped peaks. The point of greatest slope, corresponding roughly tomidpoint 42 between the peaks, is an inflection point in the plot, as the slope of the plot increases betweenpoints points FIGS. 1 and 3 , the distance between opposite sides of a wave segment in the contracted state is at a minimum at a point intermediate the looped peaks, where opposite sides of a wave appear to be touching in the two figures. - At the same time, the element can undergo a severalfold radial expansion by virtue of the ability to be close packed in a contracted state (unlike a sin wave), and still provide significant expansion between wave segment arms. This is in contrast to a sin-wave wire element in which compression at the peaks, and thus the number of wave segments that can be accommodate in the contracted state, is limited.
- Finally, and as can be appreciated from
FIGS. 3 and 4 , radial expansion of the stent produces little change in the overall length of the tubular members, preserving the overall stent length during deployment and expansion. - The stent may be formed by conventional stent construction methods involving either initial formation of the individual tubular members, and subsequent attachment of one member to another by axial connectors, or by laser cutting a thin-walled tube to have the skeletal features making up the stent, as detailed below. In the former method, the wire element may be formed by shaping a wire segment and joining the wire ends to form the desired tubular member. In the latter case, the wire element is formed by cutting and removing portions of a cylindrical tube.
- The stent preferably exhibits a relatively high degree of biocompatibility since it is implanted in the body. Where the stent is self-expanding, suitable stent materials include compressible, biocompatible polymers, ELGILOY (available from Carpenter Technology Corporation of Reading, Pa.) and PHYNOX (available from Metal Imphy of Imphy, France). Both of these metals are cobalt-based alloys which also include chromium, iron, nickel and molybdenum. Other materials for a self expanding stent include 316 stainless steel and MP35N alloy which are available from Carpenter Technology Corporation and Latrobe Steel Company of Latrobe, Pa., and superelastic Nitinol nickel-titanium alloy which is available from Shape Memory Applications of Santa Clara, Calif. Nitinol alloy contains about 45% titanium.
- In one general embodiment, the stent is formed of a shape-memory alloy having a final austenite transition temperature of between about 25° C. and 37° C. This feature allows the stent to be carried in the catheter in a martensitic state, and assume its preformed, austenite shape when expelled from the catheter and exposed to the higher body temperature at the target site. In another embodiment the shape-memory alloy has a transition temperature Md greater than 37° C., below which the alloy retains sufficient stress-induced martensitic property to allow placement of the stent at or above its Af. In other words, this allows the stent to be carried in the catheter in a stress-induced martensitic (SIM) state, and recover its preformed, austenitic shape when released from the constraints of the catheter, at a temperature that may be substantially above the final austenite temperature without significant plastic, or otherwise permanent deformation. In this embodiment, the final austenite temperature may be quite low, e.g., 4° C., or it may be room temperature or higher.
- Nitinol cylindrical tubes having desired transition temperatures, as noted above, can be prepared according to known methods. In an exemplary method of manufacture of the stent having these properties, a nitinol hypotube, e.g., 8 mil wall thickness, is subjected to centerless grinding to a wall thickness of 3 mil. The stent pattern is cut by a laser (e.g., as described by Madou in Fundamentals of Microfabrication, CRC Press, 1997). Both inner and outer surfaces are polished to a mirror finish using electro-polish techniques (e.g., as described by Madou, 1997). A gold coat may be applied by ion beam assist or by sputtering. Alternatively, or additionally, a radio-opaque marker may be affixed to the stent to improve radio-opacity.
- During manufacture, the stent is formed at the expanded condition (
FIG. 2 ), corresponding to the final deployed size (e.g. about 3-8 mm outer diameter), and heated to a temperature above the transition temperature. The stent is then subjected to thermoelastic martensitic transformation (e.g., as described in U.S. Pat. No. 5,190,546 incorporated by reference in its entirety herein) by cooling below the transition temperature range of the alloy and deformation to the contracted condition suitable for use within an intraluminal catheter. The transition temperature can be modified by varying the ratios of each metal in the alloy and in one embodiment, is preferably is within the range between about 25° C. to 45° C. at which the stent expands. A more preferred transition temperature range is between about 25° C. to 37° C. For example, the alloy can comprise 55% nickel, and 45% titanium which gives a transition temperature of about 32° C. to 33° C., which is below body temperature but above room temperature. - Nitinol cylindrical tubes having a martensite temperature MD below which the alloy can assume a stress-induced martensitic condition while being stressed to the extent necessary to place or otherwise use the device, of greater than about 37° C., preferably greater than about 40° C., are also prepared according to known methods, e.g., U.S. Pat. No. 4,505,767. For example an ideal alloy would act, at about 37° C., as a constant force spring over a strain range up to about 5% or more. This is a measurement of the degree to which an alloy, at a given temperature, can be strained in a purely austenitic state by the formation of stress-induced martensite without significant plastic deformation. In other words, the strain caused by the application of a given stress at a given temperature is substantially recoverable. In practice, the maximum stress realized occurs sometime during the process of placing a nitinol device at a given temperature. Accordingly, a suitable alloy will provide a device that is capable of substantially recovering its austenitic shape without significant plastic deformation, upon placement in the body.
- The method of placement of the stent, and a stent system for practicing the method will now be described with reference to
FIGS. 6 and 7 . The target site in the method is typically a neurovascular site, such assite 54, in the brain, which is accessible only via a tortuousvascular path 56, by which is meant a vascular path containing a plurality of bends or turns which may be greater than 90 turns, and involving vessels which are less than about 8 mm, and as small as 2-3 mm, in diameter. - Initially, a
guide catheter 60 is placed at the target site according to known methods. Then the target site is accessed by a flexible guidewire (such as described in U.S. Pat. No. 4,619,274) and a flexible catheter 64. Once the target site is reached, the catheter tube is pulled out, leaving the flexible guidewire in place. The stent-delivery catheter 62, as seen inFIG. 68 , is advanced over the guidewire until the target site is reached. - The distal end of stent-
delivery catheter 62 is shown inFIG. 7A , and includes acatheter 68 having an inner lumen having a diameter preferably between about 0.5 to 2 mm, e.g. 0.71 to 1.65 mm. Astent 70 constructed in accordance with the invention is carried in its contracted state at the distal end of the catheter. - Once the stent-delivery catheter is in place, with its distal end at the target site, the guidewire is removed and replaced with a pusher wire 63 (as shown in
FIG. 6B ) having a distal-end stabilizer 65, which has a distal head surface dimensioned to engage the proximal end of the stent. To deploy the stent the pusher wire is advanced and pushed against the stent until the stent is pushed out of the catheter, as shown inFIG. 7B . Once released from the constraints of the catheter, the stent is free to self-expand to a diameter slightly greater than the diameter of the vascular site, thus locking the stent in place at the target site. - More specifically, the method of the invention includes navigating a guide wire to the target site, moving over the guide wire, a catheter having a lumen inner diameter of 0.5 to 2 min and a distal end region in the lumen, and the stent of the invention, carried in its contracted state within the catheter's distal end region, until the catheter distal end is located at the target site. The guidewire is then replaced with a pusher wire, which is advanced within the catheter to force the stent out of the catheter into the vascular site, where stent radial expansion to its expanded state is effective to lodge the stent at the target site.
- The system of the invention used in carrying out the method includes a guidewire that can be deployed at the target site, a catheter having a lumen inner diameter of 0.5 to 2 min and a distal end region in the lumen, and adapted to be placed at the target site via such path, and the stent of the invention carried in its contracted state within the catheter's distal end region, where the catheter and stent carried therein are adapted to be moved axially along the guide wire, for placing the catheter at the target site. A pusher wire is movable through the catheter for forcing the stent out of the catheter into the vascular site, where stent radial expansion to its expanded state is effective to lodge the stent at the target site.
- The stent and system employing the stent of the present invention can be used in the treatment of a variety of vascular lesions such as an aneurysm, fistula, occlusion, or narrowing and is particularly useful in treating targets located in tortuous and narrow vessels, for example in the neurovascular system, or in certain sites within the coronary vascular system, or in sites within the peripheral vascular system such as superficial femoral, popliteal, or renal arteries.
- From the foregoing, it can be appreciated how various objects and features of the invention are met.
- The axial construction of the stent, composed of short tubular members joined by axial connections, and the ability of the joined members to flex radially, by distributed bending within the looped regions of the wire elements, allows the stent to be moved over high-angle, small-radius bends, with relatively little localized stress and metal fatigue.
- The ability of the stent to be close-packed, in its contracted state, and have a smooth wave-like character in its expanded (and expanding) state, allows the stent to expand severalfold when deployed, with a minimum risk of metal fatigue due to concentrated stresses, or damage to the vessel wall, due to sharp points on the stent. In its expanded state, the stent provides good radial strength, for holding the stent in place.
- The stent has a low profile, which may be in the 2-4 mil range for stent thickness. Finally, the stent should provide an open-network skeleton that allows for delivery of additional agents, e.g., vaso-occlusive coils, through the stent into the underlying aneurysm cavity.
- Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit of scope of the appended claims.
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/752,847 US20100222864A1 (en) | 2000-10-16 | 2010-04-01 | Neurovascular stent and method |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24110100P | 2000-10-16 | 2000-10-16 | |
US09/715,878 US7037330B1 (en) | 2000-10-16 | 2000-11-17 | Neurovascular stent and method |
US11/393,200 US7695507B2 (en) | 2000-10-16 | 2006-03-30 | Neurovascular stent and method |
US12/752,847 US20100222864A1 (en) | 2000-10-16 | 2010-04-01 | Neurovascular stent and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/393,200 Continuation US7695507B2 (en) | 2000-10-16 | 2006-03-30 | Neurovascular stent and method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100222864A1 true US20100222864A1 (en) | 2010-09-02 |
Family
ID=26934004
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/715,878 Expired - Lifetime US7037330B1 (en) | 2000-10-16 | 2000-11-17 | Neurovascular stent and method |
US11/393,200 Expired - Lifetime US7695507B2 (en) | 2000-10-16 | 2006-03-30 | Neurovascular stent and method |
US12/752,847 Abandoned US20100222864A1 (en) | 2000-10-16 | 2010-04-01 | Neurovascular stent and method |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/715,878 Expired - Lifetime US7037330B1 (en) | 2000-10-16 | 2000-11-17 | Neurovascular stent and method |
US11/393,200 Expired - Lifetime US7695507B2 (en) | 2000-10-16 | 2006-03-30 | Neurovascular stent and method |
Country Status (4)
Country | Link |
---|---|
US (3) | US7037330B1 (en) |
EP (1) | EP1339354A2 (en) |
AU (1) | AU2002213224A1 (en) |
WO (1) | WO2002034163A2 (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9023094B2 (en) | 2007-06-25 | 2015-05-05 | Microvention, Inc. | Self-expanding prosthesis |
US9050205B2 (en) | 2004-05-25 | 2015-06-09 | Covidien Lp | Methods and apparatus for luminal stenting |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9125659B2 (en) | 2004-05-25 | 2015-09-08 | Covidien Lp | Flexible vascular occluding device |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9320590B2 (en) | 2006-02-22 | 2016-04-26 | Covidien Lp | Stents having radiopaque mesh |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US9393021B2 (en) | 2004-05-25 | 2016-07-19 | Covidien Lp | Flexible vascular occluding device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US10004618B2 (en) | 2004-05-25 | 2018-06-26 | Covidien Lp | Methods and apparatus for luminal stenting |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
WO2018195160A1 (en) | 2017-04-21 | 2018-10-25 | Merit Medical Systems, Inc. | Deployable stents and related devices, systems, and methods |
US10271977B2 (en) | 2017-09-08 | 2019-04-30 | Vesper Medical, Inc. | Hybrid stent |
US10500078B2 (en) | 2018-03-09 | 2019-12-10 | Vesper Medical, Inc. | Implantable stent |
US10702405B2 (en) | 2016-03-31 | 2020-07-07 | Vesper Medical, Inc. | Intravascular implants |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10849769B2 (en) | 2017-08-23 | 2020-12-01 | Vesper Medical, Inc. | Non-foreshortening stent |
US11013523B2 (en) | 2015-01-13 | 2021-05-25 | Anaconda Biomed, S.L. | Thrombectomy device, system and method for extraction of vascular thrombi from a blood vessel |
US11357650B2 (en) | 2019-02-28 | 2022-06-14 | Vesper Medical, Inc. | Hybrid stent |
US11364134B2 (en) | 2018-02-15 | 2022-06-21 | Vesper Medical, Inc. | Tapering stent |
US11534191B2 (en) | 2019-01-11 | 2022-12-27 | Anaconda Biomed, S.L. | Loading device for loading a medical device into a catheter |
US20230036591A1 (en) * | 2021-07-30 | 2023-02-02 | Stryker Corporation | Medical stents |
US11628076B2 (en) | 2017-09-08 | 2023-04-18 | Vesper Medical, Inc. | Hybrid stent |
US11771446B2 (en) | 2020-10-19 | 2023-10-03 | Anaconda Biomed, S.L. | Thrombectomy system and method of use |
US11986195B2 (en) | 2018-10-16 | 2024-05-21 | Anaconda Biomed, S.L. | Device and a thrombectomy apparatus for extraction of thrombus from a blood vessel |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US7037330B1 (en) * | 2000-10-16 | 2006-05-02 | Scimed Life Systems, Inc. | Neurovascular stent and method |
US6989024B2 (en) * | 2002-02-28 | 2006-01-24 | Counter Clockwise, Inc. | Guidewire loaded stent for delivery through a catheter |
US9561123B2 (en) | 2002-08-30 | 2017-02-07 | C.R. Bard, Inc. | Highly flexible stent and method of manufacture |
US6878162B2 (en) | 2002-08-30 | 2005-04-12 | Edwards Lifesciences Ag | Helical stent having improved flexibility and expandability |
US8021418B2 (en) * | 2003-06-19 | 2011-09-20 | Boston Scientific Scimed, Inc. | Sandwiched radiopaque marker on covered stent |
DE10342759A1 (en) * | 2003-09-16 | 2005-04-14 | Campus Gmbh & Co. Kg | Stent with improved durability |
US7243408B2 (en) | 2004-02-09 | 2007-07-17 | Boston Scientific Scimed, Inc. | Process method for attaching radio opaque markers to shape memory stent |
US8992592B2 (en) | 2004-12-29 | 2015-03-31 | Boston Scientific Scimed, Inc. | Medical devices including metallic films |
US8998973B2 (en) | 2004-03-02 | 2015-04-07 | Boston Scientific Scimed, Inc. | Medical devices including metallic films |
US7901447B2 (en) | 2004-12-29 | 2011-03-08 | Boston Scientific Scimed, Inc. | Medical devices including a metallic film and at least one filament |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8617234B2 (en) | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
US7763064B2 (en) * | 2004-06-08 | 2010-07-27 | Medinol, Ltd. | Stent having struts with reverse direction curvature |
US20060064155A1 (en) * | 2004-09-01 | 2006-03-23 | Pst, Llc | Stent and method for manufacturing the stent |
US20060074480A1 (en) * | 2004-09-01 | 2006-04-06 | Pst, Llc | Stent and method for manufacturing the stent |
ATE466557T1 (en) * | 2004-12-09 | 2010-05-15 | Med Inst Inc | STENT WITH VARIABLE CURVATURE |
US8043323B2 (en) | 2006-10-18 | 2011-10-25 | Inspiremd Ltd. | In vivo filter assembly |
US10070977B2 (en) | 2005-05-24 | 2018-09-11 | Inspire M.D. Ltd | Stent apparatuses for treatment via body lumens and methods of use |
US8961586B2 (en) | 2005-05-24 | 2015-02-24 | Inspiremd Ltd. | Bifurcated stent assemblies |
JP4945714B2 (en) | 2005-05-25 | 2012-06-06 | タイコ ヘルスケア グループ リミテッド パートナーシップ | System and method for supplying and deploying an occlusion device in a conduit |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
EP2364676B1 (en) | 2005-06-30 | 2018-12-19 | Abbott Laboratories | Endoprosthesis having foot extensions |
US20070203563A1 (en) * | 2006-02-13 | 2007-08-30 | Stephen Hebert | System for delivering a stent |
WO2007095466A2 (en) | 2006-02-14 | 2007-08-23 | Angiomed Gmbh & Co. Medizintechnik Kg | Highly flexible stent and method of manufacture |
WO2007103236A2 (en) * | 2006-03-03 | 2007-09-13 | Prescient Medical, Inc. | Endoluminal prostheses for treating vulnerable plaque |
EP2076212B1 (en) | 2006-10-18 | 2017-03-29 | Inspiremd Ltd. | Knitted stent jackets |
EP2083767B1 (en) | 2006-10-22 | 2019-04-03 | IDEV Technologies, INC. | Devices for stent advancement |
EP3205313A1 (en) | 2006-10-22 | 2017-08-16 | IDEV Technologies, INC. | Methods for securing strand ends and the resulting devices |
CA3013758C (en) | 2006-11-22 | 2021-09-14 | Inspiremd Ltd. | Intravascular aneurysm treatment device and methods |
US8333799B2 (en) | 2007-02-12 | 2012-12-18 | C. R. Bard, Inc. | Highly flexible stent and method of manufacture |
EP2120785B1 (en) * | 2007-02-12 | 2021-12-01 | C.R. Bard, Inc. | Highly flexible stent and method of manufacture |
DE102007019772B4 (en) * | 2007-04-26 | 2019-09-26 | Acandis Gmbh | Stent and method of making a stent |
DE102007025921A1 (en) | 2007-06-02 | 2008-12-04 | Biotronik Vi Patent Ag | Medical implant, in particular stent |
DE102007030753A1 (en) | 2007-07-02 | 2009-01-08 | Acandis Gmbh & Co. Kg | stent |
US9144508B2 (en) | 2007-07-19 | 2015-09-29 | Back Bay Medical Inc. | Radially expandable stent |
US10166127B2 (en) | 2007-12-12 | 2019-01-01 | Intact Vascular, Inc. | Endoluminal device and method |
US10022250B2 (en) | 2007-12-12 | 2018-07-17 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
US9603730B2 (en) | 2007-12-12 | 2017-03-28 | Intact Vascular, Inc. | Endoluminal device and method |
US9375327B2 (en) | 2007-12-12 | 2016-06-28 | Intact Vascular, Inc. | Endovascular implant |
US7896911B2 (en) | 2007-12-12 | 2011-03-01 | Innovasc Llc | Device and method for tacking plaque to blood vessel wall |
US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
WO2009140437A1 (en) | 2008-05-13 | 2009-11-19 | Nfocus Neuromedical, Inc. | Braid implant delivery systems |
US20100160951A1 (en) * | 2008-12-19 | 2010-06-24 | Madison Michael T | Intracranial blood vessel dilation device |
US9283305B2 (en) * | 2009-07-09 | 2016-03-15 | Medtronic Vascular, Inc. | Hollow tubular drug eluting medical devices |
US20110190870A1 (en) * | 2009-12-30 | 2011-08-04 | Boston Scientific Scimed, Inc. | Covered Stent for Vascular Closure |
CN101953724B (en) * | 2010-04-19 | 2012-10-10 | 杭州启明医疗器械有限公司 | Bracket fixing head used for loading artificial valve replacement device |
US9023095B2 (en) | 2010-05-27 | 2015-05-05 | Idev Technologies, Inc. | Stent delivery system with pusher assembly |
US20120022578A1 (en) * | 2010-07-20 | 2012-01-26 | Cook Medical Technologies Llc | Frame-based vena cava filter |
US10390977B2 (en) | 2011-06-03 | 2019-08-27 | Intact Vascular, Inc. | Endovascular implant |
US8771341B2 (en) * | 2011-11-04 | 2014-07-08 | Reverse Medical Corporation | Protuberant aneurysm bridging device and method of use |
CA2986656A1 (en) | 2012-01-25 | 2013-08-01 | Intact Vascular, Inc. | Endoluminal device and method |
KR102157676B1 (en) | 2012-05-14 | 2020-09-21 | 씨. 알. 바드, 인크. | Uniformly expandable stent |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US9320630B2 (en) | 2012-12-26 | 2016-04-26 | Stryker Corporation | Implant delivery assembly and method of use |
USD723165S1 (en) | 2013-03-12 | 2015-02-24 | C. R. Bard, Inc. | Stent |
WO2014151906A1 (en) | 2013-03-14 | 2014-09-25 | Medtronic Vascular Inc. | Method for manufacturing a stent and stent manufactured thereby |
CN105530986A (en) | 2013-05-08 | 2016-04-27 | 埃姆博尔克斯公司 | Device and methods for transvascular tumor embolization with integrated flow regulation |
US9844383B2 (en) | 2013-05-08 | 2017-12-19 | Embolx, Inc. | Devices and methods for low pressure tumor embolization |
DE102014111117B4 (en) * | 2014-08-05 | 2017-11-16 | Acandis Gmbh & Co. Kg | Medical device for the treatment of neurovascular diseases, system and set with such a device and manufacturing method |
US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
WO2017023527A1 (en) | 2015-08-03 | 2017-02-09 | Advanced Endovascular Therapeutics | Novel coatings for medical devices |
US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US11464948B2 (en) | 2016-02-16 | 2022-10-11 | Embolx, Inc. | Balloon catheters and methods of manufacture and use |
US10350382B1 (en) | 2018-06-08 | 2019-07-16 | Embolx, Inc. | High torque catheter and methods of manufacture |
US9550046B1 (en) | 2016-02-16 | 2017-01-24 | Embolx, Inc. | Balloon catheter and methods of fabrication and use |
US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
US12090072B2 (en) | 2018-11-13 | 2024-09-17 | Icad Endovascular Llc | Systems and methods for delivery retrievable stents |
US10390982B1 (en) | 2018-11-13 | 2019-08-27 | Icad Endovascular Llc | Systems and methods for delivery retrievable stents |
CN109512558A (en) * | 2018-12-31 | 2019-03-26 | 杭州天启钛智能科技有限公司 | A kind of application method of intravascular stent and intravascular stent |
US20210353300A1 (en) | 2020-05-15 | 2021-11-18 | DePuy Synthes Products, Inc. | Systems and methods for treatment of defects in the vasculature |
CN113876475B (en) * | 2020-06-16 | 2024-03-19 | 上海瑛泰医疗器械股份有限公司 | Degradable magnesium alloy bracket |
CN114224561A (en) * | 2021-12-02 | 2022-03-25 | 禾木(中国)生物工程有限公司 | Intracranial vascular stent processing method |
Citations (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4503569A (en) * | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4553454A (en) * | 1983-11-28 | 1985-11-19 | Charles D. Lancaster | Nut retaining socket with replaceable nut retainer |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4795485A (en) * | 1985-03-01 | 1989-01-03 | E. I. Du Pont De Nemours And Company | Phenyl-substituted sulfonamides |
US4820298A (en) * | 1987-11-20 | 1989-04-11 | Leveen Eric G | Internal vascular prosthesis |
US4830003A (en) * | 1988-06-17 | 1989-05-16 | Wolff Rodney G | Compressive stent and delivery system |
US4955889A (en) * | 1989-02-06 | 1990-09-11 | Allergan, Inc. | Apparatus for inserting a lens into an eye and method for using same |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5067957A (en) * | 1983-10-14 | 1991-11-26 | Raychem Corporation | Method of inserting medical devices incorporating SIM alloy elements |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5217484A (en) * | 1991-06-07 | 1993-06-08 | Marks Michael P | Retractable-wire catheter device and method |
US5292331A (en) * | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
US5389106A (en) * | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5443498A (en) * | 1991-10-01 | 1995-08-22 | Cook Incorporated | Vascular stent and method of making and implanting a vacsular stent |
US5449373A (en) * | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
US5540712A (en) * | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5551954A (en) * | 1991-10-04 | 1996-09-03 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
US5562641A (en) * | 1993-05-28 | 1996-10-08 | A Bromberg & Co. Ltd. | Two way shape memory alloy medical stent |
US5597378A (en) * | 1983-10-14 | 1997-01-28 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US5630829A (en) * | 1994-12-09 | 1997-05-20 | Intervascular, Inc. | High hoop strength intraluminal stent |
US5707386A (en) * | 1993-02-04 | 1998-01-13 | Angiomed Gmbh & Company Medizintechnik Kg | Stent and method of making a stent |
US5755776A (en) * | 1996-10-04 | 1998-05-26 | Al-Saadon; Khalid | Permanent expandable intraluminal tubular stent |
US5782907A (en) * | 1995-07-13 | 1998-07-21 | Devices For Vascular Intervention, Inc. | Involuted spring stent and graft assembly and method of use |
US5817152A (en) * | 1994-10-19 | 1998-10-06 | Birdsall; Matthew | Connected stent apparatus |
US5843175A (en) * | 1997-06-13 | 1998-12-01 | Global Therapeutics, Inc. | Enhanced flexibility surgical stent |
US5843117A (en) * | 1996-02-14 | 1998-12-01 | Inflow Dynamics Inc. | Implantable vascular and endoluminal stents and process of fabricating the same |
US6053941A (en) * | 1994-05-26 | 2000-04-25 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with an end of greater diameter than its main body |
US6059813A (en) * | 1998-11-06 | 2000-05-09 | Scimed Life Systems, Inc. | Rolling membrane stent delivery system |
US6129755A (en) * | 1998-01-09 | 2000-10-10 | Nitinol Development Corporation | Intravascular stent having an improved strut configuration |
US6132460A (en) * | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent |
US6156062A (en) * | 1997-12-03 | 2000-12-05 | Ave Connaught | Helically wrapped interlocking stent |
US6171334B1 (en) * | 1998-06-17 | 2001-01-09 | Advanced Cardiovascular Systems, Inc. | Expandable stent and method of use |
US6190406B1 (en) * | 1998-01-09 | 2001-02-20 | Nitinal Development Corporation | Intravascular stent having tapered struts |
US6253443B1 (en) * | 1997-09-30 | 2001-07-03 | Scimed Life Systems, Inc. | Method of forming a stent |
US6273909B1 (en) * | 1998-10-05 | 2001-08-14 | Teramed Inc. | Endovascular graft system |
US6273910B1 (en) * | 1999-03-11 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Stent with varying strut geometry |
US6290731B1 (en) * | 1998-03-30 | 2001-09-18 | Cordis Corporation | Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm |
US6312459B1 (en) * | 1999-06-30 | 2001-11-06 | Advanced Cardiovascular Systems, Inc. | Stent design for use in small vessels |
US20010044648A1 (en) * | 1998-02-05 | 2001-11-22 | Medtronic, Inc. | Radially-expandable stent and delivery system |
US6325826B1 (en) * | 1998-01-14 | 2001-12-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6348065B1 (en) * | 1995-03-01 | 2002-02-19 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
US6355058B1 (en) * | 1999-12-30 | 2002-03-12 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque coating consisting of particles in a binder |
US6368345B1 (en) * | 1998-09-30 | 2002-04-09 | Edwards Lifesciences Corporation | Methods and apparatus for intraluminal placement of a bifurcated intraluminal garafat |
US6419692B1 (en) * | 1999-02-03 | 2002-07-16 | Scimed Life Systems, Inc. | Surface protection method for stents and balloon catheters for drug delivery |
US6451052B1 (en) * | 1994-05-19 | 2002-09-17 | Scimed Life Systems, Inc. | Tissue supporting devices |
US6464720B2 (en) * | 1997-09-24 | 2002-10-15 | Cook Incorporated | Radially expandable stent |
US6579310B1 (en) * | 2000-08-17 | 2003-06-17 | Advanced Cardiovascular Systems, Inc. | Stent having overlapping struts |
US6673106B2 (en) * | 2001-06-14 | 2004-01-06 | Cordis Neurovascular, Inc. | Intravascular stent device |
US6679910B1 (en) * | 1999-11-12 | 2004-01-20 | Latin American Devices Llc | Intraluminal stent |
US6860899B1 (en) * | 1999-04-15 | 2005-03-01 | Boston Scientific Scimed, Inc. | Method for treating neurovascular aneurysms |
US7001422B2 (en) * | 2002-09-23 | 2006-02-21 | Cordis Neurovascular, Inc | Expandable stent and delivery system |
US7037330B1 (en) * | 2000-10-16 | 2006-05-02 | Scimed Life Systems, Inc. | Neurovascular stent and method |
US7037331B2 (en) * | 2001-06-14 | 2006-05-02 | Cordis Neurovascular, Inc. | Intravascular stent device |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3249027C2 (en) | 1981-09-16 | 1992-02-20 | Medinvent Sa | Device for dilating vascular tissue - comprises helical spring element which is expanded by relatively rotating ends using external knobs |
US5578074A (en) | 1994-12-22 | 1996-11-26 | Target Therapeutics, Inc. | Implant delivery method and assembly |
US6063111A (en) * | 1998-03-31 | 2000-05-16 | Cordis Corporation | Stent aneurysm treatment system and method |
US6117140A (en) | 1998-06-26 | 2000-09-12 | Scimed Life Systems, Inc. | Stent delivery device |
KR20010089543A (en) * | 1998-12-18 | 2001-10-06 | 쿡 인코포레이티드 | Cannula Stent |
-
2000
- 2000-11-17 US US09/715,878 patent/US7037330B1/en not_active Expired - Lifetime
-
2001
- 2001-10-15 EP EP01981592A patent/EP1339354A2/en not_active Withdrawn
- 2001-10-15 AU AU2002213224A patent/AU2002213224A1/en not_active Abandoned
- 2001-10-15 WO PCT/US2001/032171 patent/WO2002034163A2/en active Application Filing
-
2006
- 2006-03-30 US US11/393,200 patent/US7695507B2/en not_active Expired - Lifetime
-
2010
- 2010-04-01 US US12/752,847 patent/US20100222864A1/en not_active Abandoned
Patent Citations (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4503569A (en) * | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US5597378A (en) * | 1983-10-14 | 1997-01-28 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US5067957A (en) * | 1983-10-14 | 1991-11-26 | Raychem Corporation | Method of inserting medical devices incorporating SIM alloy elements |
US4553454A (en) * | 1983-11-28 | 1985-11-19 | Charles D. Lancaster | Nut retaining socket with replaceable nut retainer |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4795485A (en) * | 1985-03-01 | 1989-01-03 | E. I. Du Pont De Nemours And Company | Phenyl-substituted sulfonamides |
US4820298A (en) * | 1987-11-20 | 1989-04-11 | Leveen Eric G | Internal vascular prosthesis |
US4830003A (en) * | 1988-06-17 | 1989-05-16 | Wolff Rodney G | Compressive stent and delivery system |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US4955889A (en) * | 1989-02-06 | 1990-09-11 | Allergan, Inc. | Apparatus for inserting a lens into an eye and method for using same |
US5292331A (en) * | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5217484A (en) * | 1991-06-07 | 1993-06-08 | Marks Michael P | Retractable-wire catheter device and method |
US5443498A (en) * | 1991-10-01 | 1995-08-22 | Cook Incorporated | Vascular stent and method of making and implanting a vacsular stent |
US5551954A (en) * | 1991-10-04 | 1996-09-03 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
US5540712A (en) * | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5860999A (en) * | 1993-02-04 | 1999-01-19 | Angiomed Gmbh & Co.Medizintechnik Kg | Stent and method of using same |
US5707386A (en) * | 1993-02-04 | 1998-01-13 | Angiomed Gmbh & Company Medizintechnik Kg | Stent and method of making a stent |
US5562641A (en) * | 1993-05-28 | 1996-10-08 | A Bromberg & Co. Ltd. | Two way shape memory alloy medical stent |
US5389106A (en) * | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5449373A (en) * | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
US6451052B1 (en) * | 1994-05-19 | 2002-09-17 | Scimed Life Systems, Inc. | Tissue supporting devices |
US6053941A (en) * | 1994-05-26 | 2000-04-25 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with an end of greater diameter than its main body |
US5902317A (en) * | 1994-06-01 | 1999-05-11 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5817152A (en) * | 1994-10-19 | 1998-10-06 | Birdsall; Matthew | Connected stent apparatus |
US5707388A (en) * | 1994-12-09 | 1998-01-13 | Intervascular, Inc. | High hoop strength intraluminal stent |
US5630829A (en) * | 1994-12-09 | 1997-05-20 | Intervascular, Inc. | High hoop strength intraluminal stent |
US6348065B1 (en) * | 1995-03-01 | 2002-02-19 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
US5782907A (en) * | 1995-07-13 | 1998-07-21 | Devices For Vascular Intervention, Inc. | Involuted spring stent and graft assembly and method of use |
US5843117A (en) * | 1996-02-14 | 1998-12-01 | Inflow Dynamics Inc. | Implantable vascular and endoluminal stents and process of fabricating the same |
US5755776A (en) * | 1996-10-04 | 1998-05-26 | Al-Saadon; Khalid | Permanent expandable intraluminal tubular stent |
US5843175A (en) * | 1997-06-13 | 1998-12-01 | Global Therapeutics, Inc. | Enhanced flexibility surgical stent |
US6464720B2 (en) * | 1997-09-24 | 2002-10-15 | Cook Incorporated | Radially expandable stent |
US6253443B1 (en) * | 1997-09-30 | 2001-07-03 | Scimed Life Systems, Inc. | Method of forming a stent |
US6156062A (en) * | 1997-12-03 | 2000-12-05 | Ave Connaught | Helically wrapped interlocking stent |
US6129755A (en) * | 1998-01-09 | 2000-10-10 | Nitinol Development Corporation | Intravascular stent having an improved strut configuration |
US6190406B1 (en) * | 1998-01-09 | 2001-02-20 | Nitinal Development Corporation | Intravascular stent having tapered struts |
US6325826B1 (en) * | 1998-01-14 | 2001-12-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US20010044648A1 (en) * | 1998-02-05 | 2001-11-22 | Medtronic, Inc. | Radially-expandable stent and delivery system |
US6132460A (en) * | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent |
US6358274B1 (en) * | 1998-03-27 | 2002-03-19 | Intratherapeutics, Inc. | Stent |
US6290731B1 (en) * | 1998-03-30 | 2001-09-18 | Cordis Corporation | Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm |
US6171334B1 (en) * | 1998-06-17 | 2001-01-09 | Advanced Cardiovascular Systems, Inc. | Expandable stent and method of use |
US6368345B1 (en) * | 1998-09-30 | 2002-04-09 | Edwards Lifesciences Corporation | Methods and apparatus for intraluminal placement of a bifurcated intraluminal garafat |
US6273909B1 (en) * | 1998-10-05 | 2001-08-14 | Teramed Inc. | Endovascular graft system |
US6059813A (en) * | 1998-11-06 | 2000-05-09 | Scimed Life Systems, Inc. | Rolling membrane stent delivery system |
US6419692B1 (en) * | 1999-02-03 | 2002-07-16 | Scimed Life Systems, Inc. | Surface protection method for stents and balloon catheters for drug delivery |
US6273910B1 (en) * | 1999-03-11 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Stent with varying strut geometry |
US6860899B1 (en) * | 1999-04-15 | 2005-03-01 | Boston Scientific Scimed, Inc. | Method for treating neurovascular aneurysms |
US6312459B1 (en) * | 1999-06-30 | 2001-11-06 | Advanced Cardiovascular Systems, Inc. | Stent design for use in small vessels |
US6679910B1 (en) * | 1999-11-12 | 2004-01-20 | Latin American Devices Llc | Intraluminal stent |
US6355058B1 (en) * | 1999-12-30 | 2002-03-12 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque coating consisting of particles in a binder |
US6579310B1 (en) * | 2000-08-17 | 2003-06-17 | Advanced Cardiovascular Systems, Inc. | Stent having overlapping struts |
US7037330B1 (en) * | 2000-10-16 | 2006-05-02 | Scimed Life Systems, Inc. | Neurovascular stent and method |
US7695507B2 (en) * | 2000-10-16 | 2010-04-13 | Boston Scientific Scimed, Inc. | Neurovascular stent and method |
US6673106B2 (en) * | 2001-06-14 | 2004-01-06 | Cordis Neurovascular, Inc. | Intravascular stent device |
US6960228B2 (en) * | 2001-06-14 | 2005-11-01 | Cordis Neurovascular, Inc. | Intravascular stent device |
US7037331B2 (en) * | 2001-06-14 | 2006-05-02 | Cordis Neurovascular, Inc. | Intravascular stent device |
US7001422B2 (en) * | 2002-09-23 | 2006-02-21 | Cordis Neurovascular, Inc | Expandable stent and delivery system |
Cited By (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11771433B2 (en) | 2004-05-25 | 2023-10-03 | Covidien Lp | Flexible vascular occluding device |
US12042411B2 (en) | 2004-05-25 | 2024-07-23 | Covidien Lp | Methods and apparatus for luminal stenting |
US10918389B2 (en) | 2004-05-25 | 2021-02-16 | Covidien Lp | Flexible vascular occluding device |
US9125659B2 (en) | 2004-05-25 | 2015-09-08 | Covidien Lp | Flexible vascular occluding device |
US10004618B2 (en) | 2004-05-25 | 2018-06-26 | Covidien Lp | Methods and apparatus for luminal stenting |
US9295568B2 (en) | 2004-05-25 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US9050205B2 (en) | 2004-05-25 | 2015-06-09 | Covidien Lp | Methods and apparatus for luminal stenting |
US9855047B2 (en) | 2004-05-25 | 2018-01-02 | Covidien Lp | Flexible vascular occluding device |
US10765542B2 (en) | 2004-05-25 | 2020-09-08 | Covidien Lp | Methods and apparatus for luminal stenting |
US9393021B2 (en) | 2004-05-25 | 2016-07-19 | Covidien Lp | Flexible vascular occluding device |
US9801744B2 (en) | 2004-05-25 | 2017-10-31 | Covidien Lp | Methods and apparatus for luminal stenting |
US10433988B2 (en) | 2006-02-22 | 2019-10-08 | Covidien Lp | Stents having radiopaque mesh |
US9610181B2 (en) | 2006-02-22 | 2017-04-04 | Covidien Lp | Stents having radiopaque mesh |
US9320590B2 (en) | 2006-02-22 | 2016-04-26 | Covidien Lp | Stents having radiopaque mesh |
US11382777B2 (en) | 2006-02-22 | 2022-07-12 | Covidien Lp | Stents having radiopaque mesh |
US9023094B2 (en) | 2007-06-25 | 2015-05-05 | Microvention, Inc. | Self-expanding prosthesis |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US9907643B2 (en) | 2012-10-30 | 2018-03-06 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9301831B2 (en) | 2012-10-30 | 2016-04-05 | Covidien Lp | Methods for attaining a predetermined porosity of a vascular device |
US10952878B2 (en) | 2012-10-31 | 2021-03-23 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US10206798B2 (en) | 2012-10-31 | 2019-02-19 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9561122B2 (en) | 2013-02-05 | 2017-02-07 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US11013523B2 (en) | 2015-01-13 | 2021-05-25 | Anaconda Biomed, S.L. | Thrombectomy device, system and method for extraction of vascular thrombi from a blood vessel |
US10702405B2 (en) | 2016-03-31 | 2020-07-07 | Vesper Medical, Inc. | Intravascular implants |
US10758381B2 (en) | 2016-03-31 | 2020-09-01 | Vesper Medical, Inc. | Intravascular implants |
US12076255B2 (en) | 2016-03-31 | 2024-09-03 | Vesper Medical, Inc. | Intravascular implants |
US11628075B2 (en) | 2016-03-31 | 2023-04-18 | Vesper Medical, Inc. | Intravascular implants |
US11484422B2 (en) | 2016-03-31 | 2022-11-01 | Vesper Medical, Inc. | Intravascular implants |
WO2018195160A1 (en) | 2017-04-21 | 2018-10-25 | Merit Medical Systems, Inc. | Deployable stents and related devices, systems, and methods |
EP3612140A4 (en) * | 2017-04-21 | 2021-05-12 | Merit Medical Systems, Inc. | Deployable stents and related devices, systems, and methods |
US10849769B2 (en) | 2017-08-23 | 2020-12-01 | Vesper Medical, Inc. | Non-foreshortening stent |
US10588764B2 (en) | 2017-09-08 | 2020-03-17 | Vesper Medical, Inc. | Hybrid stent |
US11628076B2 (en) | 2017-09-08 | 2023-04-18 | Vesper Medical, Inc. | Hybrid stent |
US10271977B2 (en) | 2017-09-08 | 2019-04-30 | Vesper Medical, Inc. | Hybrid stent |
US11376142B2 (en) | 2017-09-08 | 2022-07-05 | Vesper Medical, Inc. | Hybrid stent |
US10512556B2 (en) | 2017-09-08 | 2019-12-24 | Vesper Medical, Inc. | Hybrid stent |
US11364134B2 (en) | 2018-02-15 | 2022-06-21 | Vesper Medical, Inc. | Tapering stent |
US11980555B2 (en) | 2018-03-09 | 2024-05-14 | Vesper Medical, Inc. | Implantable stent |
US11344439B2 (en) | 2018-03-09 | 2022-05-31 | Vesper Medical, Inc. | Implantable stent |
US10500078B2 (en) | 2018-03-09 | 2019-12-10 | Vesper Medical, Inc. | Implantable stent |
US11986195B2 (en) | 2018-10-16 | 2024-05-21 | Anaconda Biomed, S.L. | Device and a thrombectomy apparatus for extraction of thrombus from a blood vessel |
US11534191B2 (en) | 2019-01-11 | 2022-12-27 | Anaconda Biomed, S.L. | Loading device for loading a medical device into a catheter |
US11357650B2 (en) | 2019-02-28 | 2022-06-14 | Vesper Medical, Inc. | Hybrid stent |
US11771446B2 (en) | 2020-10-19 | 2023-10-03 | Anaconda Biomed, S.L. | Thrombectomy system and method of use |
US20230036591A1 (en) * | 2021-07-30 | 2023-02-02 | Stryker Corporation | Medical stents |
Also Published As
Publication number | Publication date |
---|---|
US20060224230A1 (en) | 2006-10-05 |
AU2002213224A1 (en) | 2002-05-06 |
US7695507B2 (en) | 2010-04-13 |
EP1339354A2 (en) | 2003-09-03 |
WO2002034163A2 (en) | 2002-05-02 |
US7037330B1 (en) | 2006-05-02 |
WO2002034163A3 (en) | 2003-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7695507B2 (en) | Neurovascular stent and method | |
JP4940386B2 (en) | Stent with end member having lateral extension | |
US6425855B2 (en) | Method for making a multi-laminate stent having superelastic articulated sections | |
JP4623792B2 (en) | Intravascular stent with tapered struts | |
JP4209032B2 (en) | Multi-layered stent with superelastic joint | |
US7175654B2 (en) | Stent design having stent segments which uncouple upon deployment | |
US6863685B2 (en) | Radiopacity intraluminal medical device | |
US8882829B2 (en) | Low profile improved radiopacity intraluminal medical device | |
JP5020461B2 (en) | Improved radiopaque intraluminal medical device | |
JP2004531347A (en) | Highly flexible and flexible stent | |
JP2001245989A (en) | Self expandable stent graft | |
JP2001245990A (en) | Forming method for self-expandable stent graft | |
JP2002263195A (en) | Intravascular device with improved radiopacity | |
JP2007090074A (en) | Intraluminal medical instrument superposedly connected to one another | |
JP2002521089A (en) | Crush resistant stent | |
US7264633B2 (en) | Anvil bridge stent design | |
US11399971B2 (en) | Intraluminal device with improved flexibility and durability | |
US7214240B2 (en) | Split-bridge stent design |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: STRYKER CORPORATION, MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:025853/0548 Effective date: 20010103 Owner name: STRYKER NV OPERATIONS LIMITED, IRELAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:025853/0548 Effective date: 20010103 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:037153/0241 Effective date: 20151013 Owner name: STRYKER MEDTECH LIMITED, MALTA Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:037153/0034 Effective date: 20151013 |
|
AS | Assignment |
Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:038043/0011 Effective date: 20151013 Owner name: STRYKER MEDTECH LIMITED, MALTA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:038039/0001 Effective date: 20151013 |
|
AS | Assignment |
Owner name: STRYKER CORPORATION, MICHIGAN Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATE;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:040249/0296 Effective date: 20110103 Owner name: STRYKER NV OPERATIONS LIMITED, IRELAND Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATE;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:040249/0296 Effective date: 20110103 |
|
AS | Assignment |
Owner name: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC, MICHIGAN Free format text: CHANGE OF NAME;ASSIGNOR:STRYKER EUROPEAN HOLDINGS III, LLC;REEL/FRAME:052860/0716 Effective date: 20190226 Owner name: STRYKER EUROPEAN HOLDINGS III, LLC, DELAWARE Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER EUROPEAN HOLDINGS I, LLC;REEL/FRAME:052861/0001 Effective date: 20200519 |